Fig. (5) Block diagrams of the behavioral ocular motor system model and the PMC+ block (controlling damping within the Smooth Pursuit system) where the hypothesized central effect of acetazolamide was simulated. The gain factor “Central Therapy” (lower input to the final multiplier) was adjusted downward from its pre-acetazolamide value of 1.3.